17 reports

  • Sleep Aid Value Sales (USD million rsp) 2011/2016 and % CAGR 2011-2016 by Region
  • Sleep Aid Value Sales (USD million rsp) and Spend per Capita (USD) by Selected Market 2016
  • Sleep Aid
  • World
  • Demand
  • Bayer AG
  • Pfizer Inc.
  • GLOBAL SLEEPING AID MARKET BY PRODUCTS: MARKET SHARE 2016-2021 (%)
  • RISING PREVALENCE OF OSA
  • Sleep Aid
  • Cadwell Laboratories, Inc.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • 5.2.2.1 EROSION IN BRANDED PRESCRIPTION SLEEP AID SALES DUE TO GROWING ADOPTION OF GENERICS
  • U.S.: OVER-THE-COUNTER (OTC) SLEEP AIDS MARKET SIZE FOR INSOMNIA, BY TYPE, 2013-2021 (USD MILLION)
  • Sleep Aid
  • United States
  • Company
  • Market Size
  • Merck & Co., Inc.

On the basis of sleep disorder, the sleep aids market comprises insomnia, sleep apnea, restless legs syndrome, narcolepsy and sleep walking.

  • OTC
  • Sleep Aid
  • World
  • Market Size

Adverse effects of sleep aid medication ##. ##. ##. ##.

  • OTC
  • Sleep Aid
  • Market Size
  • COMPETITIVE LANDSCAPE
  • Sleep Aid
  • Saudi Arabia
  • Demand
  • Cigalah Group
  • GlaxoSmithKline plc

The sleeping aid products industry has witnessed huge growth in the recent years.

  • OTC
  • Sleep Aid
  • World
  • Market Size
  • HEADLINES

Also in 2017, Bayer México SA de CV launched the new product Flanax Nocto combining naproxen as an analgesic and diphenhydramine as a sleeping aid.

  • Sleep Aid
  • Mexico
  • Boehringer Ingelheim GmbH
  • Pfizer Inc.
  • Sanofi S.A.
  • COMPETITIVE LANDSCAPE

The Portuguese tend to prefer herbal/ natural sleep aid products like Valdispert and Arkocapsulas as they are perceived as having fewer side-effects and, more importantly, are not addictive.

  • Sleep Aid
  • Portugal
  • Herbalife Ltd.
  • Pfizer Inc.
  • Unipessoal, Lda
  • HEADLINES

As players aim to maintain a strong image of their recently available and marketed sleep aid products, they will most probably not expand sales channels any time soon.

  • Allergy Drug
  • Sleep Aid
  • Norway
  • Demand
  • Orkla Group
  • HEADLINES

Pharma Nord Kft, meanwhile, recently introduced the first sleep aid available in Hungary that does not contain the typical herbal extracts found in these products; instead, its active ingredient is melatonin.

  • OTC
  • Sleep Aid
  • Hungary
  • Demand
  • Sanofi S.A.
  • summarizes the minor therapeutic classes in the insomnia market.
  • 6.3 OTHER THERAPEUTIC CLASSES

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose.

  • Sleep Aid
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Neurim Pharmaceuticals Ltd
  • Pfizer Inc.

THEREFORE, PRODUCTS RELATED TO AIDING SLEEP ARE USUALLY AVOIDED, AND NATURAL TREATMENTS SUCH AS EATING WELL AND EXERCISING ARE USUALLY FAVOURED.

  • Sleep Aid
  • United Arab Emirates
  • GlaxoSmithKline plc
  • NBTY, Inc.
  • Vitabiotics Ltd
  • summarizes the minor therapeutic classes in the insomnia market.
  • 5.3 OTHER THERAPEUTIC CLASSES

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose.

  • Sleep Aid
  • Europe
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Neurim Pharmaceuticals Ltd
  • SUMMARY OF MINOR THERAPEUTIC CLASSES, 2015
  • summarizes the minor therapeutic classes in the insomnia market.

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose.

  • Sleep Aid
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Neurim Pharmaceuticals Ltd
  • Takeda Pharmaceutical Company Limited
  • SUMMARY OF MINOR THERAPEUTIC CLASSES, 2015
  • summarizes the minor therapeutic classes in the insomnia market.

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose.

  • Sleep Aid
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Neurim Pharmaceuticals Ltd
  • Takeda Pharmaceutical Company Limited
  • 5.1 BIBLIOGRAPHY

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose.

  • Sleep Aid
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Neurim Pharmaceuticals Ltd
  • Pernix Therapeutics Holdings, Inc.